Evidence map›Paper›PMID 30032138›Full record

ArticleJournal of innate immunity2019

Human Cervical Epithelial Cells Release Antiviral Factors and Inhibit HIV Replication in Macrophages.

Xi-Qiu Xu, Le Guo, Xu Wang, Yu Liu, Hang Liu, Run-Hong Zhou, Jun Gu, Jin-Biao Liu, Pei Xu, Li Zhou and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of innate immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Catch Me if You Can or Actors on the Run.Journal of innate immunity · 2019
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Xi-Qiu XuInstitute of Medical Virology, State Key Laboratory of Virology, Wuhan University School of Basic Medical Sciences, Wuhan, China.
Le GuoInstitute of Medical Virology, State Key Laboratory of Virology, Wuhan University School of Basic Medical Sciences, Wuhan, China.
Xu WangDepartment of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA.
Yu LiuInstitute of Medical Virology, State Key Laboratory of Virology, Wuhan University School of Basic Medical Sciences, Wuhan, China.
Hang LiuInstitute of Medical Virology, State Key Laboratory of Virology, Wuhan University School of Basic Medical Sciences, Wuhan, China.
Run-Hong ZhouInstitute of Medical Virology, State Key Laboratory of Virology, Wuhan University School of Basic Medical Sciences, Wuhan, China.
Jun GuInstitute of Medical Virology, State Key Laboratory of Virology, Wuhan University School of Basic Medical Sciences, Wuhan, China.
Jin-Biao LiuAnimal Biosafety Level III Laboratory at the Center for Animal Experiment, Wuhan University School of Medicine, Wuhan, China.
Pei XuSchool of Medicine (Shenzhen), Sun Yat-sen University, Guangzhou, China.
Li ZhouAnimal Biosafety Level III Laboratory at the Center for Animal Experiment, Wuhan University School of Medicine, Wuhan, Chinazhouli_jerry@whu.edu.cn.
Wen-Zhe HoInstitute of Medical Virology, State Key Laboratory of Virology, Wuhan University School of Basic Medical Sciences, Wuhan, China.
Wuhan University · CNTemple University · USSun Yat-sen University · CN

Funding

Opioids, HIV/HCV and Host Cell Innate ImmunityR01DA022177 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2007 to 2017
$2.9M
Role of miRNAs in Methamphetamine/HIV-mediated Immune ActivationR01DA045568 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2018 to 2022
$2.0M
Methamphetamine, Innate Immunity and HIVR01DA041302 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2016 to 2020
$1.8M
Opioids, Extracellular Vesicles and BBB Innate ImmunityR21DA042373 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2017 to 2018
$436k
Opioid, Astroglial TLR3/RIG-I Signaling and HIVR21DA036163 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2013 to 2014
$426k
NIDA NIH HHS R01 DA022177NIDA NIH HHS R01 DA041302NIDA NIH HHS R01 DA045568NIDA NIH HHS R21 DA036163NIDA NIH HHS R21 DA042373
6 · The paper itself

Abstract

The female reproductive tract is a major site of HIV sexual transmission. We here examined whether human cervical epithelial cells (HCEs) can be immunologically activated and produce antiviral factors against HIV. We demonstrated that HCEs (End1/E6E7 cells) possess the functional toll-like receptor (TLR)3 signaling system, which could be activated by Poly I:C and induce multiple cellular HIV restriction factors. The treatment of primary human macrophages with supernatant (SN) from TLR3-activated End1/E6E7 cell cultures resulted in HIV inhibition. This SN-mediated HIV inhibition was mainly through the induction of interferons (IFN)-β and IFN-λs, as the antibodies to IFN-β or IFN-λs receptor could effectively block the SN-mediated anti-HIV effect. Further studies showed that the incubation of macrophages with SN from the activated cervical epithelial cell cultures induced the expression of a number of IFN-stimulated genes (ISGs), including IFN-stimulated gene (ISG15), ISG56, 2', 5'-oligoadenylate synthetase 1 (OAS 1), OAS 2, Myxovirus Resistance A (MxA), MxB, and Guanylate-binding protein 5 (GBP5). In addition, TLR3-activated cells produced the CC chemokines [regulated on activation, normal T cell expressed and secreted (RANTES), Human macrophage inflammatory protein 1 alpha (MIP-1α), MIP-1β] the ligands of HIV entry co-receptor CCR5. These observations support further studies on HCEs as potentially crucial and alternative targets for immunological intervention to control and prevent HIV sexual transmission.

Indexed as

Adaptor Proteins, Signal TransducingAntiviral AgentsCells, CulturedCervix UteriChemokine CCL3Chemokines, CCEpithelial CellsFemaleHIV-1HumansImmunity, InnateInterferonsMacrophagesRNA-Binding ProteinsToll-Like Receptor 3Transcription FactorsAdaptor Proteins, Signal TransducingAntiviral AgentsChemokine CCL3Chemokines, CCIFIT1 protein, humanInterferonsRNA-Binding ProteinsTLR3 protein, humanToll-Like Receptor 3Transcription FactorsHIVHuman cervical epithelial cellsInterferon-stimulated genesMacrophagesToll-like receptor 3

Identifiers

PMID30032138
PMCPMC6338329
OpenAlexW2886306755

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.